-
Mashup Score: 4Current Grant Opportunities - 10 month(s) ago
The Lymphoma Research Foundation (LRF) announces Requests for Proposals (RFP) on a regular basis each year.
Source: Lymphoma Research FoundationCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 1LRF Welcomes Scientific Advisory Board Chair Ann S. LaCasce, MD, MMSc - 10 month(s) ago
The Lymphoma Research Foundation (LRF) is proud to welcome Ann S. LaCasce, MD, MMSc as Chair of its Scientific Advisory Board (SAB).
Source: Lymphoma Research FoundationCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
We are also excited to announce that Andrew Evens, DO, MBA, MSc, FACP (@RutgersCancer) has been elected to the role of SAB Chair-Elect and Markus Müschen, MD (@YaleMed) is joining the SAB as a new member. To learn more, visit: https://t.co/k9dmOgfqme https://t.co/9fPbMfsDT2
-
-
Mashup Score: 3Elise Chong, MD - 10 month(s) ago
Chimeric antigen receptor (CAR) T-cell therapy has become a life-saving treatment option for many people with large B-cell lymphoma. Some patients do not respond to treatment, though, and others have shortlived responses to CAR T-cell therapy. In these cases, the prognosis is typically poor. With the support of the LRF Career Development Award, Dr. Chong is investigating how the addition of a…
Source: Lymphoma Research FoundationCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
LRF's 500th grantee Dr. Elise Chong's (@PennMedicine) interest in lymphoma research began as a teenager when her mother was diagnosed with non-Hodgkin lymphoma. Now, she's working to improve outcomes for patients - learn more about her pioneering work: https://t.co/hvRcto0zEi https://t.co/MRsXKIRgp4
-
-
Mashup Score: 0The U.S. Food and Drug Administration Approves Glofitamab-gxbm (Columvi) for Diffuse Large B-Cell Lymphoma - 10 month(s) ago
On June 15, 2023 the U.S. Food and Drug Administration (FDA) announced it has approved glofitamab-gxbm (Columvi, Genentech, Inc.) for relapsed or
Source: Lymphoma Research FoundationCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
On June 15, 2023, the FDA announced it has granted accelerated approval to glofitamab-gxbm (Columvi, Genentech, Inc.) for relapsed or refractory diffuse large B-cell lymphoma (DLBCL) after two or more lines of systemic therapy. To learn more, visit us at: https://t.co/jj1xmp0o3i https://t.co/gGKwb6VxyN
-
-
Mashup Score: 1Meet the 2023 Career Development Award, Postdoctoral Fellowship, and Follicular Lymphoma Priority Research Grantees - 10 month(s) ago
The Lymphoma Scientific Research Mentoring Program (LSRMP) is a first-of-its-kind education and mentoring program for junior scientists who wish to focus on lymphoma clinical and laboratory/translational research.
Source: Lymphoma Research FoundationCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
In April, LRF announced its 2023 grant class: 27 research grants awarded to scientists based at many of the world’s leading cancer research institutions, totaling more than $5.4 million in lymphoma research. Meet our 2023 grantees in the latest Pulse: https://t.co/x4bmdc3onm
-
-
Mashup Score: 5Lymphoma Walks - 11 month(s) ago
The Lymphoma Walk is a Team LRF hosted community fundraising event where survivors, caregivers, family, friends, and supporters join together to walk in honor and in memory of those whose lives have been touched by lymphoma.
Source: Lymphoma Research FoundationCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Thank you to everyone who joined Team LRF in Minnesota last weekend and raised over $70,000 to power lifesaving research! Every step gets us closer to eradicating lymphoma - find a walk near you: https://t.co/y7Ifg9vKBt https://t.co/Geo2YYSW8B
-
-
Mashup Score: 0Chicago Lymphoma Workshop: June 17, 2023 - 11 month(s) ago
The Lymphoma Workshop provides the latest information about lymphoma, current treatment options and support issues to members of the lymphoma community.
Source: Lymphoma Research FoundationCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Our Chicago Lymphoma Workshop is around the corner! Join us on June 17 to learn the latest in lymphoma at this free patient education program chaired by Dr. Justin Kline (@UChicagoMed) & Dr. Shuo Ma (@NUFeinbergMed). To learn more and to register, visit: https://t.co/gBUZkG7j7N
-
-
Mashup Score: 0Immunotherapy - 11 month(s) ago
Immunotherapy refers to treatments that interact with the immune system. Some immunotherapy drugs recognize unique protein on the surface of lymphoma cells.
Source: Lymphoma Research FoundationCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Today marks the start of #CancerImmunotherapyAwarenessMonth. Immunotherapy uses the power of your body's immune system to target lymphoma cells. Want to learn more about the different types of immunotherapy? Visit us at: https://t.co/vzmNU5kt4b https://t.co/leA9YN0vbU
-
-
Mashup Score: 4Resources and Support - 11 month(s) ago
LRF offers a wide range of support services, educational programs and free publications for people with lymphoma and their loved ones.
Source: Lymphoma Research FoundationCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Mental health isn't just for May. As Mental Health Awareness Month winds down, we're highlighting the tools that LRF offers to support you and your mental wellbeing at every point in your lymphoma journey. Learn more about the support services we offer at: https://t.co/9K7cSLHXDT https://t.co/yIhRsOs38K
-
-
Mashup Score: 2Gil, B-Cell Lymphoma Survivor - 11 month(s) ago
Gil, B-Cell Lymphoma Survivor I was sitting alone in a stark, clean examination room on September 16, 2021, at the Dana Farber Cancer Institute (DFCI) in
Source: Lymphoma Research FoundationCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
When faced with a recurrence of non-Hodgkin #lymphoma, Gil was initially unsure where to turn. Read more about how looking into clinical trials opened the door to newfound optimism in his Story of Hope: https://t.co/yfJYWu2S20 https://t.co/Je2zDX8HGb
-
Our 2024 Early Career Investigator Grants applications are now open! Apply by September 7 to be a part of the next generation of cutting-edge #lymphoma research: https://t.co/zDd5chzCrQ https://t.co/mGYnJhbD05